Corcept Therapeutics Free Cash Flow 2010-2024 | CORT

Corcept Therapeutics free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Corcept Therapeutics annual free cash flow for 2024 was $0.196B, a 54.37% increase from 2023.
  • Corcept Therapeutics annual free cash flow for 2023 was $0.127B, a 5.83% increase from 2022.
  • Corcept Therapeutics annual free cash flow for 2022 was $0.12B, a 28.38% decline from 2021.

Corcept Therapeutics Free Cash Flow 2010-2024 | CORT

  • Corcept Therapeutics annual free cash flow for 2024 was $0.196B, a 54.37% increase from 2023.
  • Corcept Therapeutics annual free cash flow for 2023 was $0.127B, a 5.83% increase from 2022.
  • Corcept Therapeutics annual free cash flow for 2022 was $0.12B, a 28.38% decline from 2021.